bosentan anhydrous has been researched along with Ischemic Attack, Transient in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hino, A; Johns, LM; Kim, CJ; Macdonald, RL; Thisted, RA; Weir, BK | 1 |
| McCulloch, J; Patel, TR | 1 |
| Clozel, JP; Clozel, M; Gray, GA; Löffler, BM; Roux, S; Sprecher, U | 1 |
| Clozel, M; Goto, K; Saito, A; Sakai, S; Shigeno, T | 1 |
| Breu, V; Hallak, H; Lewis, AI; Rapoport, RM; Soattin, GB; Zuccarello, M | 1 |
| Löffler, BM; Seifert, V; Stenzel, W; Stolke, D; Zimmermann, M | 1 |
| Seifert, V; Zimmermann, M | 1 |
| Zimmermann, M | 1 |
1 trial(s) available for bosentan anhydrous and Ischemic Attack, Transient
| Article | Year |
|---|---|
Endothelin in cerebral vasospasm. Clinical and experimental results.
Topics: Adolescent; Adult; Aged; Aging; Animals; Bosentan; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Endothelins; Female; Hematoma; Humans; Ischemic Attack, Transient; Male; Middle Aged; Protein Precursors; Sulfonamides | 1997 |
7 other study(ies) available for bosentan anhydrous and Ischemic Attack, Transient
| Article | Year |
|---|---|
Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys.
Topics: Analysis of Variance; Animals; Blood Flow Velocity; Bosentan; Carotid Artery, Internal; Cerebral Angiography; Cerebral Arteries; Double-Blind Method; Drug Administration Schedule; Drug Evaluation, Preclinical; Endothelins; Ischemic Attack, Transient; Macaca fascicularis; Peptides, Cyclic; Prospective Studies; Random Allocation; Subarachnoid Hemorrhage; Sulfonamides; Ultrasonography, Doppler, Transcranial; Vasodilation | 1995 |
Postischemic hypoperfusion in transient global ischemia: a role for endothelins?
Topics: Animals; Arterial Occlusive Diseases; Bosentan; Cerebrovascular Circulation; Coronary Disease; Endothelins; Hypotension; Ischemic Attack, Transient; Male; Rats; Rats, Sprague-Dawley; Sulfonamides | 1995 |
The role of endothelin in experimental cerebral vasospasm.
Topics: Animals; Basilar Artery; Bosentan; Cerebral Angiography; Disease Models, Animal; Dogs; Endothelin Receptor Antagonists; Endothelins; In Vitro Techniques; Ischemic Attack, Transient; Muscle, Smooth, Vascular; Rabbits; Receptors, Endothelin; Subarachnoid Hemorrhage; Sulfonamides; Time Factors | 1995 |
The effect of bosentan, a new potent endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm.
Topics: Animals; Basilar Artery; Blood Pressure; Bosentan; Dogs; Endothelin Receptor Antagonists; Endothelins; Ischemic Attack, Transient; Muscle, Smooth, Vascular; Receptors, Endothelin; Sulfonamides; Time Factors | 1995 |
Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonists.
Topics: Administration, Oral; Animals; Basilar Artery; Bosentan; Dioxoles; Endothelin Receptor Antagonists; Ischemic Attack, Transient; Male; Rabbits; Subarachnoid Hemorrhage; Sulfonamides; Vasoconstriction | 1996 |
Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist.
Topics: Administration, Oral; Animals; Basilar Artery; Bosentan; Cerebral Angiography; Dogs; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelin Receptor Antagonists; Female; Ischemic Attack, Transient; Male; Receptors, Endothelin; Subarachnoid Hemorrhage; Sulfonamides; Vascular Resistance | 1996 |
[Prevention of cerebral vasospasms after experimental subarachnoid hemorrhage by the endothelin receptor antagonist RO 47-0203].
Topics: Animals; Basilar Artery; Bosentan; Cerebral Angiography; Dogs; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelin Receptor Antagonists; Endothelins; Infusions, Intra-Arterial; Ischemic Attack, Transient; Receptors, Endothelin; Subarachnoid Hemorrhage; Sulfonamides; Vascular Resistance | 1996 |